Trials Sponsors Conditions Drugs Pricing

Conditions

Palmar Hyperhidrosis

Keywords

Stellate ganglion block

Outcome Measures

Primary Outcomes (1)

Secretions
i.e. presence/absence of hyperhidrosis
3 months

Secondary Outcomes (1)

Compensatory hyperhidrosis
1 ]week

Study Arms (2)

Stellate ganglion block

ACTIVE COMPARATOR

bupivacaine+ lidocaine + dexamethasone injection into stellate ganglion

Drug: Bupivacaine + Lidocaine +dexamethasone

Drugs

ACTIVE COMPARATOR

librax + tryptizole

Drug: Tryptizole + Librax

Interventions

Bupivacaine + Lidocaine +dexamethasoneDrug

Sonar guided block of Stellate Ganglion By Bupivacaine + Lidocaine

Also known as: xylocaine or bupivacine, lidocaine or marcaine

Stellate ganglion block

Tryptizole + LibraxDrug

Tryptizole + Librax

Also known as:

Registry intervention entries

These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.

Grouped treatment entry
Bupivacaine + Lidocaine +dexamethasone
The registry names several treatments. This does not confirm that participants received them together or that they form a single product.
View registry record

Eligibility Criteria

Age20 Years - 45 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64)

You may qualify if:

Age from 20 to 45 years.
Both genders.

You may not qualify if:

Sponsors & Collaborators

Fayoum University
Otherlead

Study Sites (1)

Taha mohamed agmy

Al Fayyum, 084, Egypt

MeSH Terms

Interventions

BupivacaineLidocainechlordiazepoxide, clidinium drug combinationAnti-Anxiety Agents

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesAcetanilidesTranquilizing AgentsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and Uses

Study Officials

Atef M Khalil, professor
Fayoum University
PRINCIPAL INVESTIGATOR

Enrollment

46 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: NONE
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Atef Mohamed Mahmoud

Study Record Dates

First Submitted

December 9, 2024

First Posted

December 12, 2024

Study Start

January 15, 2025

Stellate Ganglion Block Versus Oral Medication in Treatment of Palmar Hyperhidrosis

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

Stellate ganglion block

Drugs

Interventions

Registry intervention entries

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

Stellate ganglion block

Drugs

Interventions

Registry intervention entries

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations